About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Aventis Pharma Deutschland GmbH v. Lupin, Ltd. (Fed. Cir. 2007) | Main | Teva and Dr. Reddy's Reach Agreement in Zoloft Suit »

September 13, 2007


You state:

"The new rules do not apply to small entities as defined by the rule. These include businesses not having more than 500 employees, not-for-profit enterprises not "dominant in its field," and government entities from populations of 50,000 or less."

Please check that. I believe the only break small entities get from 265(f)is that they don't have to comply with the pin-point citations required by 265(a)(3). They still have to comply with the other onerous provisions of the statute.

If I've missed broader breaks for SE's, please correct this post.

Babel Boy

Babel Boy:

Kevin's post has been corrected. Thank you for your comment.

Donald Zuhn

Dear Babel Boy:

Good catch. Thanks for the comment.

The comments to this entry are closed.

July 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31